Conduit Pharmaceuticals Inc. (CDT) — Net Asset Quality Index
Conduit Pharmaceuticals Inc. (CDT) has a Net Asset Quality Index of 39.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.50 Billion minus total liabilities of $2.12 Billion yields net assets of $1.38 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read Conduit Pharmaceuticals Inc. debt and liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Conduit Pharmaceuticals Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how Conduit Pharmaceuticals Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 39.5%, representing net assets of $1.38 Billion against total assets of $3.50 Billion USD. For live market cap and overall valuation, see Conduit Pharmaceuticals Inc. (CDT) total market value.
Annual Net Asset Quality Index for Conduit Pharmaceuticals Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Conduit Pharmaceuticals Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Conduit Pharmaceuticals Inc. (CDT) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 35.7% | $1.26 Billion | $3.54 Billion | $2.28 Billion | ▲ +197.7 pp |
| 2024 | -162.0% | $-6.79 Million | $4.19 Million | $10.99 Million | ▼ -155.7 pp |
| 2023 | -6.3% | $-457.00K | $7.22 Million | $7.68 Million | ▲ +201773.7 pp |
| 2022 | -201780.0% | $-10.09 Million | $5.00K | $10.09 Million | ▼ -201789.7 pp |
| 2021 | 9.7% | $20.62K | $213.12K | $192.51K | — |